Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

VJVirtual | Role of telemedicine in the time of COVID-19

Samreen Ahmed • 4 May 2020
General

Samreen Ahmed, FRCP, MD, University Hospitals of Leicester, UK, gives her thoughts on the role of telemedicine in the time of COVID-19. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Samreen Ahmed

Osimertinib and chemotherapy as the standard of care in EGFRm NSCLC
1:40
Osimertinib and chemotherapy as the standard of care in EGFRm NSCLC
Samreen Ahmed • 8 Sep 2025
FLAURA2 outcomes by EGFR mutation subtype in advanced NSCLC
1:34
FLAURA2 outcomes by EGFR mutation subtype in advanced NSCLC
Samreen Ahmed • 8 Sep 2025
Challenges in treating HER2-mutant lung cancer and emerging therapeutic approaches
1:06
Challenges in treating HER2-mutant lung cancer and emerging therapeutic approaches
Samreen Ahmed • 4 Mar 2025
Optimizing immunotherapy in lung cancer: balancing intensification and de-escalation
1:18
Optimizing immunotherapy in lung cancer: balancing intensification and de-escalation
Samreen Ahmed • 4 Mar 2025

Related Videos

AI governance and validation in robotic cancer surgery
1:12
AI governance and validation in robotic cancer surgery
Marie Hanaoka • 1 Jul 2026
Does toxicity differ between patients treated with SABR for one versus five lesions?
0:39
Does toxicity differ between patients treated with SABR for one versus five lesions?
Robert Olson • 16 May 2026
5-year toxicity following SABR: insights from the SABR-5 trial
0:42
5-year toxicity following SABR: insights from the SABR-5 trial
Robert Olson • 16 May 2026
How should results from the SABR-5 trial guide future SABR studies?
1:05
How should results from the SABR-5 trial guide future SABR studies?
Robert Olson • 16 May 2026
The content of VJOncology is intended for healthcare professionals